ClinicalTrials.Veeva

Menu

Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure

H

Heart and Diabetes Center North-Rhine Westfalia

Status

Completed

Conditions

Pleural Effusion
Heart Failure

Treatments

Device: Non-invasive ventilation

Study type

Observational

Funder types

Other

Identifiers

NCT03189654
HDZNRW-KA_010_TB

Details and patient eligibility

About

There are no investigations so far whether an application of positive pressure during non-invasive ventilation might be a therapeutic option for transudative pleural effusion in patients with heart failure. In view of the pathophysiological process with pleural effusion resulting from an increase in intravascular hydrostatic pressure, non-invasive ventilation might provide an improvement.

The aim of the present study is to investigate whether an additional non-invasive ventilation therapy leads to an improved suppression of pleural effusion in heart failure patients.

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted to our hospital on a routine or emergency basis
  • Patients with heart failure according to the current ESC guidelines and chronic pleural effusion with clinical indication for pleurocentesis
  • Non-invasively determined cardiac index of < 2.5 l/min/m²
  • BNP > 300 pg/ml
  • Transudative pleural effusion according to Light criteria
  • Effective pleurocentesis with residual effusion on the side affected of < 500 ml
  • Tolerance of non-invasive ventilation without subjective or objective hemodynamic impairment as verified during a test ventilation
  • No change in drug or other therapy for the duration of the study (5 days)

Exclusion criteria

  • Psychological or neurological concomitant disease making an informed consent impossible
  • Pregnancy
  • Pneumothorax or pneumomediastinum
  • Pathologically low blood pressure, particularly associated with intravascular volume depletion
  • Liquor discharge, recent head surgery or trauma
  • Severe bullous lung disease
  • Dehydration
  • Current ventilation therapy
  • Bilateral pleural effusion > 500 ml at the time of enrolment
  • Exudative pleural effusion

Trial design

11 participants in 2 patient groups

Treatment group
Description:
Non-invasive ventilation after pleurocentesis
Treatment:
Device: Non-invasive ventilation
Control group
Description:
Oxygen Administration via nasal tube

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems